Teva must face government's kickback claims over Copaxone - judge | Reuters
Exterior of the pharmaceutical manufacturing plant of Teva Pharmaceutical Industries located in Har Hotzvim also called Campus of Science-Rich Industries a high-tech industrial park located in northwest Jerusalem. Israel Stock Photo -
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits | IndustryWeek
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva Pharmaceuticals' massive layoffs | Communist Party of Israel
Teva's collapse – Israel's biotech recovery - The Jerusalem Post
Teva, Israel's Biggest Country, In Opioid Legal Trouble – The Forward
Teva freezes layoffs of some 800 Israeli employees | The Times of Israel
Teva Israel enters medical cannabis market with new partnership | Reuters
Teva Israel steps into the ring to begin distributing medical cannabis - The Jerusalem Post
Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia
Exterior of the pharmaceutical manufacturing plant of Teva Pharmaceutical Industries located in Har Hotzvim also called Campus of Science-Rich Industries a high-tech industrial park located in northwest Jerusalem. Israel Stock Photo -
UPDATED: Israeli Drugmaker Teva To Cut Quarter Of Global Work Force - Pharmaceutical Processing World
Teva Pharmaceutical Industries' Jerusalem oral solid dosage plant (OSD) is seen December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM - Tags: BUSINESS DRUGS SOCIETY Stock Photo -
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Former Teva officials said to return $50m over fines paid by drugmaker | The Times of Israel
Teva, Technion To Collaborate On Cancer, Neurobiology Research
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
